APOB and scleroderma: Apo A-I levels were lower in scleroderma patients than in the controls (1.41 ± 0.2 g/L vs. 1.52 ± 0.22 g/L, p < 0.05), but the Apo-B and Lp (a) levels were not significantly different between the groups (1.06 ± 0.25 g/L vs. 0.99 ± 0.25, p = 0.15; 65 (35–138) mg/L vs. 64.5 (32.25–112.3, p = 0.24) mg/L, respectively, Table 4).